Nova Mentis Announces Change of Directors

newsfileFeb 26 08:30 ET

Nova Mentis Applauds Government Decision to Create Rare Disease Advisory Group

newsfileNov 3, 2023 08:30 ET

Nova Mentis Announces Participant Screening Underway in Canada's First Psilocybin Clinical Trial for Fragile X Syndrome

newsfileAug 30, 2023 08:30 ET

Nova Mentis to Enter MRNA AI Diagnostics Business

newsfileApr 26, 2023 08:32 ET

Nova Mentis Begins Recruitment in First-of-its-Kind Health Canada Psilocybin Trial

newsfileApr 18, 2023 08:36 ET

Nova Mentis Receives Institutional Review Board Approval to Commence Psilocybin Clinical Trial

newsfileApr 11, 2023 08:31 ET